No 1 Date of announcement 2025/02/17 Time of announcement 17:38:49 Subject Announcement for the expected date of Board of Directors Meeting for the 2024 financial statements is 2025/02/25 Date of events 2025/02/17 To which item it meets paragraph 31 Date of a notice of the board of directors meeting is issued:2025/02/17 Expected date of...Read More

Published: 2025-02-07   No 1 Date of announcement 2025/02/07 Time of announcement 18:36:27 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2025/02/07 To which item it meets paragraph 51 Date of occurrence...Read More

Published: 2025-02-05 2025-02-05 09:00 ZHUHAI, China, Feb. 5, 2025 /PRNewswire/ — EyeYon Medical is proud to announce its expansion in China with the establishment of a new subsidiary, Zhuhai EyeYon Medical Technology Co., Ltd. (珠海爱眼医疗科技有限公司), which will address unmet market needs as well as accelerate its growth trajectory. This strategic move underscores a significant commitment to expanding its reach and impact in a...Read More

Published: 2025-01-08   No 1 Date of announcement 2025/01/08 Time of announcement 17:57:21 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2025/01/08 To which item it meets paragraph 51 Date of occurrence...Read More

Published: 2025-01-08   No 2 Date of announcement 2025/01/08 Time of announcement 17:57:40 Subject Announcement for the Company’s commitments made when applying for listing of stock and its subsequent implementation. Date of events 2025/01/08 To which item it meets paragraph 51 1. Date of occurrence of the event: 2024/10/08 2. Company name:Diamond Biofund Inc. 3....Read More

Published: 2024-12-25 2024-12-25 On the 24th, SINEW PHARMA announced that its innovative pain relief drug, SNP-810, a high-liver-safety acetaminophen, has successfully completed toxicology testing on large animals (dogs) conducted by the globally renowned Charles River Laboratories. The results confirmed that the drug maintains excellent safety even at extremely high doses (equivalent to 38 tablets of...Read More

Published: 2024-12-23   No 1 Date of announcement 2024/12/23 Time of announcement 16:31:59 Subject Announce for the Company’s Board of Directors the resolution to rename the “Nomination Committee” to the “Sustainable Development and Nomination Committee.” Date of events 2024/12/23 To which item it meets paragraph 6 Date of occurrence of the event:2024/12/23 Name of the...Read More

Published: 2024-12-23   No 2 Date of announcement 2024/12/23 Time of announcement 16:39:39 Subject Announce on behalf of the subsidiary Diamond Biofund I Inc. regarding the termination of external fundraising. Date of events 2024/12/23 To which item it meets paragraph 51 Date of occurrence of the event:2024/12/23 Company name:Diamond Biofund I Inc. Relationship to the...Read More

Published: 2024-12-23   No 3 Date of announcement 2024/12/23 Time of announcement 16:41:29 Subject Announce on behalf of the subsidiary Diamond Biofund II Inc. regarding the termination of external fundraising. Date of events 2024/12/23 To which item it meets paragraph 51 Date of occurrence of the event:2024/12/23 Company name:Diamond Biofund II Inc. Relationship to the...Read More

Published: 2024-12-19   No 1 Date of announcement 2024/12/19 Time of announcement 17:30:14 Subject The Company announces the invitation to participate in the online investor conference held by Hua Nan Securities. Date of events 2024/12/26 To which item it meets paragraph 12 Date of institutional investor conference: 2024/12/26 Time of institutional investor conference: 15:00 (GMT+8)...Read More